OxThera

OxThera

OxThera

OxThera develops products for the treatment of metabolic disorders resultingfrom excess levels of oxalate.
Raised
$88.5M
Follow us
Alexa global traffic share
Latest funding Show all
$10,521,261
Undisclosed funding - 2014
Team Size
1000+
Employees
€32,000,000 Venture capital
FinSMEs , N9 - Nordic 9

OxThera Raises €32M in Funding